| Literature DB >> 27698470 |
Kazuo Nakajima1, An-A Kazuno1, John Kelsoe2, Moe Nakanishi3, Toru Takumi3, Tadafumi Kato1.
Abstract
Knockin (KI) mouse carrying a point mutation has been an invaluable tool for disease modeling and analysis. Genome editing technologies using the CRISPR/Cas system has emerged as an alternative way to create KI mice. However, if the mice carry nucleotide insertions and/or deletions (InDels) in other genes, which could have unintentionally occurred during the establishment of the KI mouse line and potentially have larger impact than a point mutation, it would confound phenotyping of the KI mice. In this study, we performed whole exome sequencing of multiple lines of F1 heterozygous Ntrk1 KI mice generated using the CRISPR/Cas system in comparison to that of a wild-type mouse used as a control. We found three InDels in four KI mice but not in a control mouse. In vitro digestion assay suggested that each InDel occurred as a de novo mutation, was carried-over from the parental mice, or was incorporated through the Cas9 nuclease mediated off-target cleavage. These results suggest that frequency of InDels found in KI mice generated by the CRISPR/Cas technology is not high, but cannot be neglected and careful assessment of these mutations is warranted.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27698470 PMCID: PMC5048150 DOI: 10.1038/srep34703
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Generation of the Ntrk1 knockin mice.
(a) Schematic of the target site at the Ntrk1 locus. In the double-stranded DNA, the PAM sequence is capitalized, and the sgRNA target is underlined. In the donor DNA, the single-strand oligodeoxynucleotide, the replaced nucleotides are capitalized (for KI, green; for creating the underlined TfiI site, red). (b) Sequence chromatograms for the target site of wild-type mice (top), Neuro2A cell line transfected with the CRISPR/Cas expression vector (middle), and heterozygous (F1) KI offspring (bottom). , nucleotide deletion (3 bp); , , nucleotide changes.
Figure 2Analysis of the 3 InDels identified.
(a) Sequence information of the 3 InDel sites. Yellow highlighted nucleotides, PAM sequence for Ntrk1 target site; gray highlighted nucleotides, putative PAM sequence for Aspa insertion site. Boldface nucleotides, matched bases between the guide sequence and the Aspa sequence. (b) In vitro cleavage assay for the 3 InDel sites. Cleavage templates: PCR products amplified from wild-type B6J mouse genomic DNA including the sites for Ntrk1 target, InDels (Zfp365, Alox12, Aspa) and Ntrk2 genomic region corresponding to the Ntrk1 target.
Number of nucleotide variations confirmed.
| Mouse samples | |||||
|---|---|---|---|---|---|
| 268-1 | 283-1 | 306-1 | 316-2 | B6J | |
| Insertion | — | 1 | — | 1 | — |
| Deletion | — | 1 | — | — | — |
| Total InDels | — | 2 | — | 1 | — |
| Total SNVs | 4 | 5 | 3 | 4 | 3 |
| Total Variants | 4 | 7 | 3 | 5 | 3 |